Trial intelligence / Profile preview

Pharmacokinetics of DW-1021 vs Pelubiprofen and Tramadol in Healthy Vietnamese Males

NCT07032558Phase 1Recruiting

Sponsor
Hai Phong University of Medicine and Pharmacy
Start
Sep 2025
Primary completion
Sep 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of DW-1021 in pain (2 arms), sponsored by Hai Phong University of Medicine and Pharmacy. Primary endpoints: Maximum Plasma Concentration and Area Under the Plasma Concentration-Time Curve from Time 0 to Last Measurable Concentration. Started Sep 2025; status: recruiting.

02

Drugs

DW-1021
03

Conditions

pain

Beyond the preview

Go deeper on NCT07032558.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07032558.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call